Intelligent Bio Solutions Ratios (2019-2025) | INBS

Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Profitability
Gross Margin (Quarter)
68.42%7.23%11.19%29.18%26.08%21.67%39.76%36.73%46.84%
EBT Margin (Quarter)
-1,942.94%-703.23%-9,164.97%-201.10%-1,948.26%-698.25%-174.60%-348.44%-597.03%-1,389.76%-609.84%-322.03%-264.42%-362.44%-308.93%-371.37%-349.94%
EBIT Margin (Quarter)
-1,196.16%-324.10%-9,158.69%-201.67%-1,949.84%-697.57%-174.89%-350.62%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%-312.43%-372.76%-351.28%
EBITDA Margin (Quarter)
-2,026.23%-688.99%-9,929.13%-205.49%-1,941.97%-692.18%-180.72%-388.40%-16.54%-1,405.01%-588.31%-306.90%-248.83%-380.04%-284.13%-395.06%-334.03%
Operating Margin (Quarter)
-1,196.16%-324.10%-9,158.69%-201.67%-1,949.84%-697.57%-174.89%-350.62%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%-312.43%-372.76%-351.28%
Net Margin (Quarter)
-1,942.94%-703.23%-9,164.97%-201.10%-1,948.26%-698.25%-174.60%-348.44%-597.03%-1,389.76%-609.84%-322.03%-264.42%-362.44%-308.93%-371.37%-349.94%
FCF Margin (Quarter)
-4,830.25%-274.51%-17,962.77%-398.02%-801.82%-151.80%-144.33%-544.98%-667.50%-551.01%-131.86%-164.78%-375.51%-296.68%-273.67%-382.68%-380.01%
Efficiency
Inventory Average (Quarter)
0.70M0.86M0.97M0.95M0.91M0.83M0.76M0.72M0.69M0.66M
Assets Average (Quarter)
18.71M19.66M20.48M17.17M14.80M13.36M11.26M14.10M14.36M10.51M9.53M8.76M12.93M15.41M12.75M10.20M9.13M8.92M
Equity Average (Quarter)
-4.13M7.87M17.33M15.44M14.25M11.77M9.37M7.62M5.87M7.73M8.09M4.81M2.46M2.20M7.08M9.59M7.07M5.08M4.57M3.97M
Invested Capital (Quarter)
-3.05M19.21M15.91M15.02M13.57M10.05M8.70M9.38M6.22M10.78M6.42M3.69M1.24M3.15M11.00M8.18M5.95M4.20M4.94M3.00M
Asset Utilization Ratio (Quarter)
0.020.040.050.060.150.170.150.160.150.220.280.220.260.300.33
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-67.46-61.33-69.22-122.06-167.71-323.31
Debt to Equity (Quarter)
0.020.000.000.010.000.430.200.050.080.110.250.070.01
Debt Ratio (Quarter)
0.020.000.000.000.000.230.100.030.040.040.040.030.01
Equity Ratio (Quarter)
0.940.910.690.710.660.610.530.510.570.560.360.140.360.650.590.510.480.520.36
Times Interest Earned (Quarter)
-67.46-61.33-69.22-122.06-167.71-323.31
Valuation
Enterprise Value (Quarter)
-19.92M-14.32M-12.62M-12.66M-11.25M-10.83M-8.32M-5.83M-3.00M-2.38M-0.11M-0.12M-1.24M-0.14M-0.15M-4.15M-2.40M-2.98M-1.20M
Return Ratios
Return on Sales (Quarter)
-0.19%-0.07%-0.92%-0.02%-0.19%-0.07%-0.02%-0.03%-0.06%-0.14%-0.06%-0.03%-0.03%-0.04%-0.03%-0.04%-0.03%
Return on Capital Employed (Quarter)
-9.80%-34.89%-35.97%-67.61%-68.51%-95.91%-91.20%-72.99%-110.70%-272.15%-518.47%-384.39%-140.78%-103.26%-148.19%-185.37%-226.74%
Return on Assets (Quarter)
0.00%0.00%0.00%-0.01%0.00%-0.01%-0.01%0.00%-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter)
0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.03%-0.06%-0.06%-0.01%-0.01%-0.01%-0.02%-0.02%-0.02%